Le Vet Beheer

Le Vet is a Dutch pharmaceutical company specializing in the development, registration, and marketing of generic veterinary medicines for companion animals and livestock. Based in Oudewater, the company focuses on providing high-quality, cost-effective alternatives to off-patent veterinary drugs across various therapeutic areas, including anti-infectives, analgesics, and endocrine treatments. Le Vet is particularly noted for its expertise in navigating European regulatory pathways to secure product licenses. In February 2018, the company was acquired by Dechra Pharmaceuticals for approximately €340 million, a move that significantly bolstered Dechra's European product portfolio and development pipeline. Today, Le Vet operates as a subsidiary of Dechra, continuing to support the global veterinary market with its extensive range of licensed products.